Apotex Inc - Company Profile
Powered by 
All the sales intelligence you need on Apotex Inc in one solution.
- Save hours of research time with a comprehensive
Sales Intelligence Solution.
- Understand how Apotex Inc fits into your total
addressable market and Ideal Customer Profile.
- Gain competitive edge with triggers that tell you
when and how to engage with Apotex Inc.
Get in touch about GlobalData Company reports
Contact the team or request a demo to find out how our data can drive your business forward
Apotex Inc (Apotex) is a Canadian-based global health company engaged in pharmaceutical licensing, product acquisitions, and commercialization across the Americas. The company offers a diversified portfolio of generic and branded prescriptions, over-the-counter products, and biosimilar pharmaceutical products in major therapeutic areas. Notable brands associated with Apotex include Adrenalin, Atarax, Bacid, Bezalip SR, Blexten, Cambia, and Cerebyx. Apotex serves industries such as dermatology, neuroscience, oncology, ophthalmology, osteoporosis, pain management, and women's health. Apotex has manufacturing and distribution sites in Canada, the US, Mexico, and India, targeting markets across the Americas and beyond. Apotex is headquartered in Toronto, Ontario, Canada.
Headquarters
Canada
Address
150 Signet Drive, Toronto, Ontario, M9L1T9
Website
www1.apotex.com
Telephone
1 800 2684623
No of Employees
6,000
Industry
Pharmaceuticals and Healthcare
Apotex Inc premium industry data and analytics
Products and Services
| Products | Brands |
|---|---|
| - | Adrenalin |
| Generic Pharmaceuticals | Atarax |
| Non-Prescription Medicines | Bacid |
| XYZ | XYZ |
| XYZ | XYZ |
| XYZ | XYZ |
History
History section provides information on new products, mergers, acquisitions, expansions, approvals, and many more key events.
| Year | Event | Description |
|---|---|---|
| 2026 | Acquisitions/Mergers/Takeovers | In August, the company through its subsidiary acquired the Talicia business from RedHill Biopharma Ltd. |
| 2026 | Asset Purchase | In July, the company acquired a branded commercial drug portfolio from Cumberland Pharmaceuticals for US$100 million. |
| 2025 | New Products/Services | In May, the company announced the launch of nilotinib capsules, the first generic version of Tasigna in the US. |
Competitor Comparison
| Key Parameters | Apotex Inc | Duchesnay Inc | Eloxx Pharmaceuticals Inc | Liminal BioSciences Inc | Resilience Biotechnologies Inc |
|---|---|---|---|---|---|
| Headquarters | Canada | Canada | United States of America | Canada | United States of America |
| City | Toronto | Blainville | Arlington | Laval | La Jolla |
| State/Province | Ontario | Quebec | Massachusetts | Quebec | California |
| No. of Employees | 6,000 | - | 10 | - | - |
| Entity Type | Private | Private | Public | Private | Private |
Executives
| Name | Position | Board | Since | Age |
|---|---|---|---|---|
| Jeff Watson | Chief Executive Officer; Director; President | Executive Board | 2026 | - |
| Brian McClelland | Chief Financial Officer | Senior Management | 2023 | - |
| Francesco Tallarico | Chief Legal Officer; Head - Government Relations | Senior Management | 2023 | - |
| Carina Vassilieva | Chief Human Resources Officer | Senior Management | 2023 | - |
| Ariel Alon | Chief Operations Officer | Senior Management | 2023 | - |
| Non Dignissim Eros | Proin vel | Convallis | 2026 | XY |
| Non Dignissim Eros | Proin vel | Convallis | 2026 | XY |
| Non Dignissim Eros | Proin vel | Convallis | 2026 | XY |
Still looking?
Have you found what you were looking for? From start-ups to market leaders, uncover what they do and how they do it.
Explorer
Access more premium companies when you subscribe to Explorer